TODAY'S HEADLINES
Although intensive glycemic control has been the standard of care for delaying the onset and slowing the progression of microvascular disease, treatment burden and unwanted effects like weight gain, hypoglycemia, and gastrointestinal side effects do affect patients’ quality of life. Patient preferences and their views of treatment burden need to be considered when making decisions about glycemic treatment, according to a report published online for JAMA Internal Medicine. » More |
|
FDA's review of the hypertension drug olmesartan found no clear evidence of increased heart risks for diabetes patients, but the agency will require additional information be provided on the drug's labels. » More |
|
FDA has approved Afrezza, insulin delivered through a small inhaler that is believed to act more rapidly than injectable insulins such Humalog and NovoLog. FDA said Afrezza (MannKind Corp.) offers a new treatment option for patients with diabetes. » More |
|
Recently, Drug Topics published an article about nine pharmacists suing Mercy Medical Group, alleging that they were fired because of their age. Read the story, here. Have you experienced age discrimination in your pharmacy setting? Take part in our survey and let us know! » More |
Continuing Education
This month's article is the fifth in a year-long CPE series, Medication
Therapy Management Considerations for Adult Patients with Cardiovascular
Disease. From February 2014 through January 2015, pharmacists can earn up
to 24 hours of CPE credit with 12 monthly knowledge-based activities form
the University of Connecticut School of Pharmacy and Drug Topics
.
The goal of this month's activity is to review the stages and
pharmacologic strategies relevant to medication therapy management of
heart failure
.
To read and print the article with TEST QUESTIONS, click here.To proceed to the online exams and earn up to 2 CPE credits, click here to log in.
Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide
or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login
for all the NABP programs and services you will need throughout your career. |
|
|
Like
Tweet
